Development of machine learning-based malignant pericardial effusion-related model in breast cancer: Implications for clinical significance, tumor immune and drug-therapy
Article in Heliyon (March 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinases
Preprint in bioRxiv (February 2024)
New Opportunities in the Systemic Treatment of Hepatocellular Carcinoma—Today and Tomorrow
Article in International Journal of Molecular Sciences (January 2024)